Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Acq. announced
Inv. presentation
|
|
Solid Biosciences Inc. (SLDB)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/05/2023 |
4
| SMITH IAN F (Director) has filed a Form 4 on Solid Biosciences Inc.|
Txns:
| Exercised 15,569 restricted stock units
@ $0 |
|
| 08/14/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
| 07/06/2023 |
4
| SMITH IAN F (Director) has filed a Form 4 on Solid Biosciences Inc.|
Txns:
| Exercised 15,570 restricted stock units
@ $0 |
|
| 06/09/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 06/08/2023 |
4
| Keresty Georgia (Director) has filed a Form 4 on Solid Biosciences Inc.|
Txns:
| Granted 9,650 options to buy
@ $6.37, valued at
$61.5k
|
|
| 06/08/2023 |
4
| Kahn Clare (Director) has filed a Form 4 on Solid Biosciences Inc.|
Txns:
| Granted 9,650 options to buy
@ $6.37, valued at
$61.5k
|
|
| 06/08/2023 |
4
| Sullivan Lynne Marie (Director) has filed a Form 4 on Solid Biosciences Inc.|
Txns:
| Granted 9,650 options to buy
@ $6.37, valued at
$61.5k
|
|
| 06/08/2023 |
4
| Nagendran Sukumar (Director) has filed a Form 4 on Solid Biosciences Inc.|
Txns:
| Granted 9,650 options to buy
@ $6.37, valued at
$61.5k
|
|
| 06/08/2023 |
4
| Ganot Ilan (Director) has filed a Form 4 on Solid Biosciences Inc.|
Txns:
| Sold 487 shares
@ $4.8541, valued at
$2.4k
Exercised 1,553 restricted stock units
@ $0
Exercised 1,583 restricted stock units
@ $0
Granted 9,650 options to buy
@ $6.37, valued at
$61.5k
|
|
| 06/08/2023 |
4
| SMITH IAN F (Director) has filed a Form 4 on Solid Biosciences Inc.|
Txns:
| Exercised 15,569 restricted stock units
@ $0
Granted 9,650 options to buy
@ $6.37, valued at
$61.5k
|
|
| 06/08/2023 |
4
| Freed Martin I (Director) has filed a Form 4 on Solid Biosciences Inc.|
Txns:
| Granted 9,650 options to buy
@ $6.37, valued at
$61.5k
|
|
| 06/08/2023 |
4
| RA CAPITAL MANAGEMENT, L.P. (10% Owner) has filed a Form 4 on Solid Biosciences Inc.|
Txns:
| Granted 9,650 options to buy
@ $6.37, valued at
$61.5k
|
|
| 06/08/2023 |
4
| Koppel Adam (10% Owner) has filed a Form 4 on Solid Biosciences Inc.|
Txns:
| Granted 9,650 options to buy
@ $6.37, valued at
$61.5k
|
|
| 06/08/2023 |
4
| Stone Adam Leo (Director) has filed a Form 4 on Solid Biosciences Inc.|
Txns:
| Granted 9,650 options to buy
@ $6.37, valued at
$61.5k
|
|
| 06/08/2023 |
4
| PERCEPTIVE ADVISORS LLC (10% Owner) has filed a Form 4 on Solid Biosciences Inc.|
Txns:
| Granted 9,650 options to buy
@ $6.37, valued at
$61.5k
|
|
| 06/06/2023 |
S-8
| Form S-8 - Securities to be offered to employees in employee benefit plans: |
| 05/11/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
| 04/27/2023 |
ARS
| Form ARS - Annual Report to Security Holders: |
| 04/27/2023 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 04/27/2023 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
| 03/23/2023 |
424B5
| Form 424B5 - Prospectus [Rule 424(b)(5)]: |
| 03/23/2023 |
S-8
| Form S-8 - Securities to be offered to employees in employee benefit plans: |
| 03/23/2023 |
10-K
| Annual Report for the period ended December 31, 2022 |
| 03/20/2023 |
8-K
| Quarterly results |
| 03/13/2023 |
8-K
| Regulation FD Disclosure Interactive Data |
| 03/06/2023 |
4
| Ganot Ilan (Director) has filed a Form 4 on Solid Biosciences Inc.|
Txns:
| Exercised 1,584 restricted stock units
@ $0 |
|
| 02/13/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/13/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/07/2023 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 02/03/2023 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 01/31/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/31/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/26/2023 |
S-3
| Form S-3 - Registration statement under Securities Act of 1933: |
| 01/11/2023 |
4
| Tan Kevin (CFO & Treasurer) has filed a Form 4 on Solid Biosciences Inc.|
Txns:
| Granted 90,000 options to buy
@ $6, valued at
$540k
Granted 45,000 restricted stock units
@ $0 |
|
|
|
|